SEC Form 4 · accession 0001140361-15-010307
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 7:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 2, 2015 | M | 3,000 | $12.99 | A | 46,195 | I | Shares held by Bienaime Family Trust |
| Common StockF1,F3,F2 | Mar 2, 2015 | S | 3,000 | $107.9643 | D | 43,195 | I | Shares held by Bienaime Family Trust |
| Common StockF4 | Mar 2, 2015 | S | 5,000 | $108.4389 | D | 220,157 | D | |
| Common StockF5 | Mar 3, 2015 | S | 5,000 | $107.4193 | D | 215,157 | D | |
| Common Stock | Mar 4, 2015 | M | 500 | $9.86 | A | 43,695 | I | Shares held by Bienaime Family Trust |
| Common StockF6 | Mar 4, 2015 | S | 916 | $107.7079 | D | 42,279 | I | Shares held by Bienaime Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F2,F7 | $12.99 | Mar 2, 2015 | M | 3,000 | D | Nov 11, 2006 | May 10, 2016 | Common Stock | 3,000 | 61,500 | I |
| Stock Option (right to buy Common Stock)F8,F5,F7 | $12.99 | holding | — | — | — | Nov 11, 2006 | May 10, 2016 | Common Stock | 10,000 | 10,000 | I |
| Stock Option (right to buy Common Stock)F8,F5,F7 | $12.99 | holding | — | — | — | Nov 11, 2006 | May 10, 2016 | Common Stock | 10,000 | 10,000 | I |
| Stock Option (right to buy Common Stock)F8,F5,F7 | $12.99 | holding | — | — | — | Nov 11, 2006 | May 10, 2016 | Common Stock | 10,000 | 10,000 | I |
| Stock Option (right to buy Common Stock)F8,F5,F7 | $12.99 | holding | — | — | — | Nov 11, 2006 | May 10, 2016 | Common Stock | 10,000 | 10,000 | I |
| Stock Option (right to buy Common Stock)F8,F5,F7 | $12.99 | holding | — | — | — | Nov 11, 2006 | May 10, 2016 | Common Stock | 20,000 | 20,000 | I |
Explanation of responses
- F1Trade made pursuant to a 10b5-1 plan executed November 6, 2014
- F2The reporting person an his spouse act as trustees for the Bienaime Family Trust
- F3The price in column 4 is an average weighted price. The price actually received ranged from $106.96 to $108.66. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F4The price in column 4 is an average weighted price. The price actually received ranged from $107.29 to $108.82. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F5The price in column 4 is an average weighted price. The price actually received ranged from $106.33 to $108.49. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F6The price in column 4 is an average weighted price. The price actually received ranged from $109.68 to $109.725. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F7Original option grant cests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.
- F8The reporting person's spouse is the trustee of each child's trust.